Literature DB >> 26159730

Chikungunya virus pathogenesis: From bedside to bench.

Thérèse Couderc1, Marc Lecuit2.   

Abstract

Chikungunya virus (CHIKV) is an arbovirus transmitted to humans by mosquito bite. A decade ago, the virus caused a major outbreak in the islands of the Indian Ocean, then reached India and Southeast Asia. More recently, CHIKV has emerged in the Americas, first reaching the Caribbean and now extending to Central, South and North America. It is therefore considered a major public health and economic threat. CHIKV causes febrile illness typically associated with debilitating joint pains. In rare cases, it may also cause central nervous system disease, notably in neonates. Joint symptoms may persist for months to years, and lead to arthritis. This review focuses on the spectrum of signs and symptoms associated with CHIKV infection in humans. It also illustrates how the analysis of clinical and biological data from human cohorts and the development of animal and cellular models of infection has helped to identify the tissue and cell tropisms of the virus and to decipher host responses in benign, severe or persistent disease. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World".
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arbovirus; Arthralgia; Chikungunya virus; Emerging virus; Mosquito-borne

Mesh:

Year:  2015        PMID: 26159730     DOI: 10.1016/j.antiviral.2015.07.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  34 in total

1.  Fatty Acid Synthase Promotes the Palmitoylation of Chikungunya Virus nsP1.

Authors:  Na Zhang; Hongjian Zhao; Leiliang Zhang
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

2.  Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological Study.

Authors:  Brieg Couzigou; Anne Criquet-Hayot; Emilie Javelle; Sandrine Tignac; Edith Mota; François Rigaud; Alizé Alain; Odile Troisgros; Sandrine Pierre-Francois; Sylvie Abel; Rishika Banydeen; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2018-05-24       Impact factor: 2.345

Review 3.  Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems.

Authors:  Carlos Pineda; Roberto Muñoz-Louis; Carlo V Caballero-Uribe; Diego Viasus
Journal:  Clin Rheumatol       Date:  2016-08-24       Impact factor: 2.980

4.  Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme.

Authors:  Kristen M Feibelman; Benjamin P Fuller; Linfeng Li; Daniel V LaBarbera; Brian J Geiss
Journal:  Antiviral Res       Date:  2018-04-20       Impact factor: 5.970

5.  Host ESCRT factors are recruited during chikungunya virus infection and are required for the intracellular viral replication cycle.

Authors:  Shiho Torii; Yasuko Orba; Michihito Sasaki; Koshiro Tabata; Yuji Wada; Michael Carr; Jody Hobson-Peters; Roy A Hall; Ayato Takada; Takasuke Fukuhara; Yoshiharu Matsuura; William W Hall; Hirofumi Sawa
Journal:  J Biol Chem       Date:  2020-04-27       Impact factor: 5.157

6.  Characterization of β-d-N4-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus.

Authors:  Maryam Ehteshami; Sijia Tao; Keivan Zandi; Hui-Mien Hsiao; Yong Jiang; Emily Hammond; Franck Amblard; Olivia O Russell; Andres Merits; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

7.  Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.

Authors:  Jing Jin; Nathan M Liss; Dong-Hua Chen; Maofu Liao; Julie M Fox; Raeann M Shimak; Rachel H Fong; Daniel Chafets; Sonia Bakkour; Sheila Keating; Marina E Fomin; Marcus O Muench; Michael B Sherman; Benjamin J Doranz; Michael S Diamond; Graham Simmons
Journal:  Cell Rep       Date:  2015-12-10       Impact factor: 9.423

Review 8.  The Range of Neurological Complications in Chikungunya Fever.

Authors:  T Cerny; M Schwarz; U Schwarz; J Lemant; P Gérardin; E Keller
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

9.  Immunoglobulin-responsive chikungunya encephalitis: two case reports.

Authors:  Stephanie Suzanne de O Scott; Pedro Braga-Neto; Lícia Pacheco Pereira; Paulo Ribeiro Nóbrega; Francisco de Assis Aquino Gondim; Manoel Alves Sobreira-Neto; Claudia Carvalho Mendes Schiavon
Journal:  J Neurovirol       Date:  2017-06-02       Impact factor: 3.739

10.  Ferritin, Erythrocyte Sedimentation Rate, and C-Reactive Protein Level in Patients with Chikungunya-Induced Chronic Polyarthritis.

Authors:  Maira Sant Anna Genaro; Micheli Said de Marchi; Matheus Yung Perin; Isabelle Silva Cossô; Renata Dezengrini Slhessarenko
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.